Dan Leonard, the newly named CEO of the Association for Accessible Medicines, believes that generic and biosimilar medicines are an important bridge shoring up efforts to contain COVID-19 until a safe, effective vaccine is developed. Leonard cities the resilient, diverse supply chains that have enabled essential generic medicines to reach the hospitals and patients that need them most: “Today, patients with chronic conditions and fighting the virus have access to the medicines they need when they need them. Our job is to work with policymakers to ensure that continues. I appreciate the Board’s confidence in me to join this high-performing and effective advocacy team that has shown its commitment to patients and the membership by elevating awareness of the market challenges facing the generic and biosimilar industry and advancing thoughtful and achievable solutions.”
Leonard goes on to say, “The COVID-19 pandemic continually demonstrates that our industry is fundamentally strong and critical to saving lives and containing costs for those stricken with the virus. Our medicines, from the injectables that are essential to placing a patient on a ventilator to the steroid drugs that have reduced the risk of death in COVID patients by one-third, have proven themselves to truly be the bridge to a vaccine.”
Read more here.